Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-3-hydroxy-4-(4-methylpiperazin-1-yl)-1-phenylbutan-2-yl]-3-methylbutanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-3-hydroxy-4-(4-methylpiperazin-1-yl)-1-phenylbutan-2-yl]-3-methylpentanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-3-hydroxy-4-(4-methylpiperazin-1-yl)-1-phenylbutan-2-yl]-3-phenylpropanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-3-hydroxy-4-(4-methylpiperazin-1-yl)-1-phenylbutan-2-yl]-4-methylpentanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]-3-methylbutanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]-3-methylpentanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]-3-phenylpropanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]-4-methylpentanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-3-methylbutanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-3-methylpentanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-3-phenylpropanamide | - |
Plasmodium falciparum | |
(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-4-methylpentanamide | - |
Plasmodium falciparum | |
(2S)-N-[(2R,3S)-4-(1,4'-bipiperidin-1'-yl)-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanamide | - |
Plasmodium falciparum | |
(2S)-N-[(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylbutanamide | - |
Plasmodium falciparum | |
(2S)-N-[(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylpentanamide | - |
Plasmodium falciparum | |
(2S)-N-[(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanamide | - |
Plasmodium falciparum | |
(2S)-N-[(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-methylpentanamide | - |
Plasmodium falciparum | |
(2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylbutanamide] | - |
Plasmodium falciparum | |
(2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylpentanamide] | - |
Plasmodium falciparum | |
(2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanamide] | - |
Plasmodium falciparum | |
(2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-methylpentanamide] | - |
Plasmodium falciparum | |
Chloroquine | - |
Plasmodium falciparum | |
di-tert-butyl [piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]biscarbamate | - |
Plasmodium falciparum | |
tert-butyl [(2R,3S)-3-hydroxy-4-(4-methylpiperazin-1-yl)-1-phenylbutan-2-yl]carbamate | - |
Plasmodium falciparum | |
tert-butyl [(2R,3S)-4-(1,4'-bipiperidin-1'-yl)-3-hydroxy-1-phenylbutan-2-yl]carbamate | - |
Plasmodium falciparum | |
tert-butyl [(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]carbamate | - |
Plasmodium falciparum | |
tert-butyl [(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate | - |
Plasmodium falciparum | |
tert-butyl [(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate | - |
Plasmodium falciparum |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
Hemoglobin + H2O | Plasmodium falciparum | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Plasmodium falciparum | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Hemoglobin + H2O | - |
Plasmodium falciparum | ? | - |
? | |
Lys-Pro-Ile-Glu-Phe-NO2Phe-Arg-Leu + H2O | - |
Plasmodium falciparum | Lys-Pro-Ile-Glu-Phe + NO2Phe-Arg-Leu | - |
? |
Synonyms | Comment | Organism |
---|---|---|
plasmepsin 4 | - |
Plasmodium falciparum |
Plm IV | - |
Plasmodium falciparum |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0033 | - |
(2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylbutanamide] | at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | |
0.0274 | - |
(2S)-N-[(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylpentanamide | at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | |
0.05 | - |
(2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylpentanamide] | at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | |
0.05 | - |
(2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-methylpentanamide] | at pH 4.5, temperature not specified in the publication | Plasmodium falciparum |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00116 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | tert-butyl [(2R,3S)-4-(1,4'-bipiperidin-1'-yl)-3-hydroxy-1-phenylbutan-2-yl]carbamate | |
0.00125 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-N-[(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylbutanamide | |
0.0013 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanamide] | |
0.00133 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-3-phenylpropanamide | |
0.00213 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]-4-methylpentanamide | |
0.00256 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | tert-butyl [(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate | |
0.00296 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]-3-phenylpropanamide | |
0.00311 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | di-tert-butyl [piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]biscarbamate | |
0.00314 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-N-[(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanamide | |
0.00324 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylpentanamide] | |
0.00328 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-N-[(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylpentanamide | |
0.00336 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-3-methylpentanamide | |
0.00341 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-3-hydroxy-4-(4-methylpiperazin-1-yl)-1-phenylbutan-2-yl]-3-phenylpropanamide | |
0.0038 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]-3-methylbutanamide | |
0.00437 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]-3-methylpentanamide | |
0.00458 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-3-hydroxy-4-(4-methylpiperazin-1-yl)-1-phenylbutan-2-yl]-3-methylbutanamide | |
0.00459 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-3-methylbutanamide | |
0.00461 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-3-hydroxy-4-(4-methylpiperazin-1-yl)-1-phenylbutan-2-yl]-4-methylpentanamide | |
0.0049 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | tert-butyl [(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate | |
0.00512 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-methylpentanamide] | |
0.00527 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-4-[4-(4-fluorobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-4-methylpentanamide | |
0.0054 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | tert-butyl [(2R,3S)-4-(4-ethylpiperazin-1-yl)-3-hydroxy-1-phenylbutan-2-yl]carbamate | |
0.00633 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(2R,3S)-3-hydroxy-4-(4-methylpiperazin-1-yl)-1-phenylbutan-2-yl]-3-methylpentanamide | |
0.00696 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-N-[(2R,3S)-4-[4-(4-bromobenzyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-methylpentanamide | |
0.00728 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S,2'S)-N,N'-[piperazine-1,4-diylbis[(2R,3S)-3-hydroxy-1-phenylbutane-4,2-diyl]]bis[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-methylbutanamide] | |
0.00854 | - |
at pH 4.5, temperature not specified in the publication | Plasmodium falciparum | (2S)-N-[(2R,3S)-4-(1,4'-bipiperidin-1'-yl)-3-hydroxy-1-phenylbutan-2-yl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanamide |